Prostate Cancer

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Latest News

prostate-specific antigen (PSA) test | Image credit: © luchschenF - © stock.adobe.com
Therapy to Prevent PSA-Related Recurrence May Not Boost Prostate Cancer Survival

September 12th 2023

Treatments intended to reduce biochemical recurrence in patients with prostate cancer may not improve long-term survival, recent research showed.

prostate cancer on AI board
Top Prostate Cancer News from Summer 2023

September 3rd 2023

FDA approved
Solid Cancer Approvals from Summer 2023

September 1st 2023

FDA Grants Xtandi Priority Review for Certain Patients with Prostate Cancer
FDA Grants Xtandi Priority Review for Certain Patients with Prostate Cancer

August 29th 2023

ChatGPT Often Fails to Recommend Correct Cancer Treatments
ChatGPT Often Fails to Recommend Correct Cancer Treatments

August 28th 2023

More News

Treatment Options Available for mCRPC

Treatment Options Available for mCRPC

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
John Litten: Participating on a PARP Clinical Trial for mCRPC

John Litten: Participating on a PARP Clinical Trial for mCRPC

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Talking About Gene Testing in Prostate Cancer

Talking About Gene Testing in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Testing for Mutations in Prostate Cancer

Testing for Mutations in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Prostate Cancer: Learning About Treatment Options

Prostate Cancer: Learning About Treatment Options

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Receiving a Prostate Cancer Diagnosis

Receiving a Prostate Cancer Diagnosis

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Metastatic Castration-Resistant Prostate Cancer Overview

Metastatic Castration-Resistant Prostate Cancer Overview

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
The Future of PARP Inhibitors in Prostate Cancer

The Future of PARP Inhibitors in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Patient’s Role in Decision-Making for Prostate Cancer

Patient’s Role in Decision-Making for Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Quality of Life With Prostate Cancer

Quality of Life With Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
FDA-Approved PARP Inhibitors for Prostate Cancer

FDA-Approved PARP Inhibitors for Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Impact of BRCA Mutations in Prostate Cancer

Impact of BRCA Mutations in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Genetic Counseling for Prostate Cancer

Genetic Counseling for Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Diagnosis of Prostate Cancer

Diagnosis of Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020
Smartphone App Encourages Smoking Cessation, House Passes Veteran’s Prostate Cancer Treatment and Research Act, and More

Smartphone App Encourages Smoking Cessation, House Passes Veteran’s Prostate Cancer Treatment and Research Act, and More

Conor Killmurray
September 25th 2020

From a new study showing that the iCanQuit smoking cessation app is more likely to work than typical guidelines, to the House unanimously passing the Veteran’s Prostate Cancer Treatment and Research Act, here’s what’s happening in the cancer landscape this week.

Lynparza Significantly Improves Survival in Subset of Patients with Metastatic Prostate Cancer

Lynparza Significantly Improves Survival in Subset of Patients with Metastatic Prostate Cancer

Kristie L. Kahl
September 23rd 2020

The PARP inhibitor Lynparza reduced the risk for death by 31% in men with metastatic castration-resistant prostate cancer compared with Xtandi or Zytiga plus the corticosteroid prednisone.

The Future of PARP Inhibitors in Prostate Cancer

The Future of PARP Inhibitors in Prostate Cancer

Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
September 16th 2020
Patient’s Role in Decision-Making for Prostate Cancer

Patient’s Role in Decision-Making for Prostate Cancer

Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
September 16th 2020
Quality of Life With Prostate Cancer

Quality of Life With Prostate Cancer

Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
September 16th 2020
FDA Approved PARP Inhibitors for Prostate Cancer

FDA Approved PARP Inhibitors for Prostate Cancer

Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
September 16th 2020
Impact of BRCA Mutations in Prostate Cancer

Impact of BRCA Mutations in Prostate Cancer

Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
September 16th 2020
Genetic Counseling for Prostate Cancer

Genetic Counseling for Prostate Cancer

Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
September 16th 2020
Diagnosis of Prostate Cancer

Diagnosis of Prostate Cancer

Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
September 16th 2020
CURE® Speaking Out Launches Video Series in Recognition of National Prostate Cancer Awareness Month

CURE® Speaking Out Launches Video Series in Recognition of National Prostate Cancer Awareness Month

CURE staff
September 8th 2020

Charles J. Ryan, M.D., internationally recognized for his research on prostate cancer, discusses risk factors, treatments and racial disparities associated with the disease.

The Latest News and Updates in Prostate Cancer

The Latest News and Updates in Prostate Cancer

CURE staff
September 5th 2020

A roundup of the latest news and updates for patients with prostate cancer from CURE®.

Kristie L. Kahl and Dr. Charles Ryan

Addressing Racial Disparities in Prostate Cancer

Kristie L. Kahl
September 1st 2020
Kristie L. Kahl and Dr. Charles Ryan

Learning About Advanced Prostate Cancer

Kristie L. Kahl
September 1st 2020
Kristie L. Kahl and Dr. Charles Ryan

Understanding Genetics and Genomics in Prostate Cancer

Kristie L. Kahl
September 1st 2020
Kristie L. Kahl and Dr. Charles Ryan

The Basics of Prostate Cancer

Kristie L. Kahl
September 1st 2020
Genetics Remains Paramount for Moving Rare Cancers Forward

Genetics Remains Paramount for Moving Rare Cancers Forward

Debu Tripathy, M.D.
August 30th 2020

The evolving understanding of cancer genetics is allowing for clinicians to look at how to move rare cancer treatments, and identifications, forward.

<1
...
456789101112
...
22>